Literature DB >> 28968269

Immunohistochemical Characterization of Cancer-associated Fibroblasts in Oral Squamous Cell Carcinoma.

Raísa C Dourado1, Lia P A Porto2, Águida C G H Leitão3, Paloma S G Cerqueira1, Jean N Dos Santos3, Luciana M P Ramalho3, Flávia C A Xavier3.   

Abstract

Myofibroblasts are differentiated contractile cells that can secrete extracellular matrix components, cytokines, proteases, and proangiogenic factors. In neoplastic processes such as oral squamous cell carcinoma (OSCC), myofibroblasts are recognized as cancer-associated fibroblasts (CAFs) and actively participate in tumor progression. As the presence of myofibroblasts in the stroma may be an important parameter of invasion and proliferation, the aim of this study was to evaluate the presence of CAFs in OSCC by immunophenotyping and their association with histologic classification and clinicopathologic parameters. A total of 34 formalin-fixed, paraffin-embedded samples of OSCC were analyzed for CAF histology and immunophenotype established on the basis of the simultaneous immunohistochemical expression of α-SMA, fibronectin, FSP1, HHF35, and vimentin. According to the histologic classification of CAFs, 16 (47%) cases were classified as the mature subtype and 18 (53%) as the immature subtype. CAF immunophenotype was detected in 19 (56%) cases, and the immunophenotype was variable in 15 (44%) cases. The CAFs immunophenotype was significantly associated with the immature histologic subtype. Immunohistochemical expression of α-SMA, fibronectin, FSP1, HHF35, and vimentin represents a suitable CAF immunophenotype in OSCC. The CAF immunophenotype is associated with the immature histologic subtype. The characterization of CAFs may identify tumors with a distinct biological profile in OSCC. Studies extending the investigation of CAFs to OSCC are needed to determine the actual role of this cell population as a possible prognostic marker.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28968269     DOI: 10.1097/PAI.0000000000000486

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  5 in total

1.  Comparisons of cancer-associated fibroblasts in the intratumoral stroma and invasive front in colorectal cancer.

Authors:  Gyung Mo Son; Myeong-Sook Kwon; Dong-Hoon Shin; Nari Shin; Dongryeol Ryu; Chi-Dug Kang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

2.  Cancer associated fibroblasts are distinguishable from peri-tumor fibroblasts by biological characteristics in TSCC.

Authors:  Pengfei Ba; Xiaojuan Zhang; Miao Yu; Linxia Li; Xiaoyu Duan; Mingying Wang; Shuyan Lv; Guo Fu; Pishan Yang; Chengzhe Yang; Qinfeng Sun
Journal:  Oncol Lett       Date:  2019-07-04       Impact factor: 2.967

3.  MiR-942 regulates the function of breast cancer cell by targeting FOXA2.

Authors:  Jinku Zhang; Zhiqiang Zhang; Jirui Sun; Qiushuang Ma; Wenming Zhao; Xue Chen; Haizhi Qiao
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

4.  Apatinib inhibits macrophage-mediated epithelial-mesenchymal transition in lung cancer.

Authors:  Shuliang Liu; Lingfei Su; Xuri Mu; Yubo Shi; Aifeng Zhang; Xingping Ge
Journal:  RSC Adv       Date:  2018-06-12       Impact factor: 4.036

Review 5.  Cancer: a mirrored room between tumor bulk and tumor microenvironment.

Authors:  Pablo Hernández-Camarero; Elena López-Ruiz; Juan Antonio Marchal; Macarena Perán
Journal:  J Exp Clin Cancer Res       Date:  2021-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.